Sandostatin Lar 30 mg powder and solvent for suspension for injection
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
15-01-2024
Karatteristiċi tal-prodott
(SPC)
30-01-2023
Ingredjent attiv:
Октреотид
Disponibbli minn:
Novartis Pharma GmbH
Kodiċi ATC:
H01CB2
INN (Isem Internazzjonali):
Octreotide
Dożaġġ:
30 mg powder and solvent for suspension for injection
Sommarju tal-prodott:
Sandostatin LAR, 30 mg powder and solvent for suspension for injection
Data ta 'l-awtorizzazzjoni:
2015-03-11
